These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 861958)

  • 21. New molecular targeted therapies in thyroid cancer.
    Milano A; Chiofalo MG; Basile M; Salzano de Luna A; Pezzullo L; Caponigro F
    Anticancer Drugs; 2006 Sep; 17(8):869-79. PubMed ID: 16940797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Chemotherapy of highly malignant thyroid tumors].
    Kober F; Heiss A; Keminger K; Depisch D
    Wien Klin Wochenschr; 1990 Apr; 102(9):274-6. PubMed ID: 2165340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Medullary carcinoma of the thyroid].
    Olesen LL
    Ugeskr Laeger; 1984 Oct; 146(43):3260-4. PubMed ID: 6506297
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment of advanced medullary thyroid cancer with an alternating combination of doxorubicin-streptozocin and 5 FU-dacarbazine. Groupe d'Etude des Tumeurs à Calcitonine (GETC).
    Nocera M; Baudin E; Pellegriti G; Cailleux AF; Mechelany-Corone C; Schlumberger M
    Br J Cancer; 2000 Sep; 83(6):715-8. PubMed ID: 10952773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy on anaplastic thyroid carcinoma of valproic acid alone or in combination with doxorubicin, a synthetic chenodeoxycholic acid derivative, or lactacystin.
    Kim TH; Yoo YH; Kang DY; Suh H; Park MK; Park KJ; Kim SH
    Int J Oncol; 2009 May; 34(5):1353-62. PubMed ID: 19360347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thyroid cancers. II. Medullary, anaplastic, lymphoma, sarcoma, squamous cell.
    Austin JR; el-Naggar AK; Goepfert H
    Otolaryngol Clin North Am; 1996 Aug; 29(4):611-27. PubMed ID: 8844733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thyroid diffuse large B cell lymphoma (DLBCL) following thyroid medullary cancer: long-term complete remission with R-CHOP therapy.
    Dai CW; Zhang GS; Pei MF; Shen JK
    Ann Hematol; 2009 Jul; 88(7):701-2. PubMed ID: 19015853
    [No Abstract]   [Full Text] [Related]  

  • 28. [Failure of chemotherapoy in thyroid cancers (author's transl)].
    Droz JP; Charbord P; Rougier P; Parmentier C
    Bull Cancer; 1981; 68(4):350-2. PubMed ID: 7198496
    [No Abstract]   [Full Text] [Related]  

  • 29. Case 37-1979: Thyroid carcinoma.
    Katsas AG
    N Engl J Med; 1980 Feb; 302(8):467. PubMed ID: 7351958
    [No Abstract]   [Full Text] [Related]  

  • 30. Anaplastic cancer, lymphoma, and metastases of the thyroid gland.
    Pasieka JL
    Surg Oncol Clin N Am; 1998 Oct; 7(4):707-20. PubMed ID: 9735130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of octreotide in the treatment of medullary thyroid carcinoma.
    Frank-Raue K; Ziegler R; Raue F
    Horm Metab Res Suppl; 1993; 27():44-7. PubMed ID: 8330871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Letter: Indifferent cancer of the thyroid gland. Remission by adriamycine].
    Fiorentino M; Grigoletto E; Guglielmi M
    Nouv Presse Med; 1975 Nov; 4(40):2884. PubMed ID: 1215199
    [No Abstract]   [Full Text] [Related]  

  • 33. The effect of calcitriol and its analogues on proliferation and hormone expression in cultured cells of thyroid medullary carcinomas.
    Zabel M; Flig K; Gebarowska E; Surdyk-Zasada J
    Folia Morphol (Warsz); 2003 Nov; 62(4):463-5. PubMed ID: 14655142
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Therapy of metastatic medullary thyroid gland carcinoma with the somatostatin analog octreotide].
    Frank-Raue K; Raue F; Ziegler R
    Med Klin (Munich); 1995 Feb; 90(2):63-6. PubMed ID: 7708002
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An appraisal of the hormonal control of carcinoma of the thyroid gland.
    Block GE
    Surg Gynecol Obstet; 1971 Feb; 132(2):289-90. PubMed ID: 5547410
    [No Abstract]   [Full Text] [Related]  

  • 36. New agents in the treatment for malignancies of the salivary and thyroid glands.
    Mehra R; Cohen RB
    Hematol Oncol Clin North Am; 2008 Dec; 22(6):1279-95, xi. PubMed ID: 19010274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemotherapy for the carcinoid syndrome.
    Harris AL
    Cancer Chemother Pharmacol; 1981; 5(3):133-8. PubMed ID: 7296750
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Response of medullary thyroid carcinomas and carcinoid tumors to adriamycin.
    Ravry MJ
    Cancer Treat Rep; 1977; 61(1):106-7. PubMed ID: 861958
    [No Abstract]   [Full Text] [Related]  

  • 39. Medullary carcinoma of the thyroid treated by low-dose adriamycin.
    Porter AT; Ostrowski MJ
    Br J Clin Pract; 1990 Nov; 44(11):517-8. PubMed ID: 2282316
    [No Abstract]   [Full Text] [Related]  

  • 40. Failure of medullary carcinoma of the thyroid to respond to doxorubicin therapy.
    Husain M; Alsever RN; Lock JP; George WF; Katz FH
    Horm Res; 1978; 9(1):22-5. PubMed ID: 618781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.